U.S. markets closed

Endurance RP Limited (0575.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
0.151-0.006 (-3.82%)
At close: 1:37PM HKT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.157
Open0.155
Bid0.151 x 0
Ask0.153 x 0
Day's Range0.150 - 0.155
52 Week Range0.081 - 0.290
Volume1,120,000
Avg. Volume2,115,368
Market Cap362.312M
Beta (5Y Monthly)0.34
PE Ratio (TTM)N/A
EPS (TTM)-0.021
Earnings DateMar 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 08, 2013
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Fortacin™ Receives Extremely Encouraging Assessment in US Market Research Analysis

      Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce that Fortacin™, a European, Hong Kong and Macau approved treatment for PE receives a detailed market assessment by MME, one of the leading global market research companies for health care in the United States.

    • PR Newswire

      Deep Longevity Repurposes a Blood Aging Clock for Saliva Samples

      Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce the publication of its Frontiers in Aging article "Adapting blood DNAm aging clocks for use in saliva samples with cell-type deconvolution".

    • PR Newswire

      Deep Longevity Releases an AI-based Predictor of COVID Time-To-Death

      Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly-owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce the publication of its COVID Risk Calculator that can estimate the expected time-to-death of hospitalized COVID-19 patients. The calculator is based on a peer-reviewed academic publication titled "Increased pace of aging in COVID-related